Business
Why CSL shares could be dirt cheap in 2025
Image source: Getty Images
Now could be the time to pounce on CSL Ltd (ASX: CSL) shares.
That’s the view of analysts at Goldman Sachs, which have just initiated coverage on the company.
CSL is a global biotechnology company with a world-class portfolio of therapies. This includes therapies that…
Continue Reading
-
General12 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
Business23 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM